new endpoints in clinical trials to better serve patients
Published 7 years ago • 519 plays • Length 11:19Download video MP4
Download video MP3
Similar videos
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
1:31
mrd as an endpoint in clinical trials
-
1:54
a novel clinical trial endpoint for acute gvhd
-
1:52
evaluating surrogacy endpoints in cll clinical trials
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
16:35
key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
0:45
key trials in cll and designing a concept for treatment
-
28:08
dr. gaby hobbs, md: diagnosis and initial treatment options for et, pv & mf
-
11:30
cll patient story - diane george
-
58:42
what's new in ms research: a look into the future of multiple sclerosis treatment - july 2021
-
3:21
long-term outcomes from key clinical trials presented at ash 2023
-
1:51
checkpoint inhibition in the treatment of mpns
-
2:22
improve study: mrd assessment as an endpoint to define treatment length and intensity in cll
-
3:16
new mpn clinical trials & drugs in 2021
-
17:23
updates in cll: key clinical trials in the frontline and r/r setting, pre-clinical data and mrd
-
0:42
upcoming trial updates in all
-
1:41
addressing diversity, equity, and inclusion in hematology clinical trials across europe
-
3:26
the risk of thrombotic events in patients with mgus: an analysis from the istopmm trial
-
1:46
standardization mrd monitoring in clinical trials
-
7:55
clinical trials of fixed duration treatments & novel targets in cll
-
2:14
long-term follow-up results from the rathl trial: response-adapted treatment for advanced stage hl